1. Body mass index in patients with moderate‐to‐severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry. (15th July 2013) Authors: Carrascosa, J.M.; Vilavella, M.; Garcia‐Doval, I.; Carretero, G.; Vanaclocha, F.; Daudén, E.; Gómez‐García, F.J.; Herrera‐Ceballos, E.; De la Cueva Dobao, P.; Belinchón, I.; Sánchez‐Carazo, J.L.; Alsina, M.; López‐Estebaranz, J.L.; Ferrán, M.; Peral, F.; Torrado, R.; Rivera, R.; Jiménez‐Puya, R.;... Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 28:Number 7(2014:Jul.) Page Start: 907 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5‐year observational study of clinical practice: 2008–2013 results of the Biobadaderm registry. (31st March 2014) Authors: Carretero, G.; Ferrandiz, C.; Dauden, E.; Vanaclocha Sebastián, F.; Gómez‐García, F.J.; Herrera‐Ceballos, E.; De la Cueva‐Dobao, P.; Belinchón, I.; Sánchez‐Carazo, J.L.; Alsina‐Gibert, M.; López‐Estebaranz, J.L.; Ferrán, M.; Torrado, R.; Carrascosa, J.M.; Carazo, C.; Rivera, R.; Jiménez‐Puya, R.;... Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 1(2015:Jan.) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗